Ribosomal protein L23a pseudogene 91 (RPL23AP91)

Ribosomal protein L23a pseudogene 91 (RPL23AP91) is a processed pseudogene derived from the ribosomal protein L23a gene. Pseudogenes are genomic DNA sequences similar to normal genes but non-functional; they typically lack the ability to encode functional proteins due to mutations, deletions, or lack of regulatory elements. RPL23AP91 does not encode a functional ribosomal protein and is not known to be involved in protein synthesis or any cellular process. While some ribosomal protein L23a pseudogenes have been studied for possible regulatory or non-coding RNA functions, there is no evidence for a specific biological or disease-related role for RPL23AP91. Thus, it is neither a therapeutic target nor a molecule with known pharmacological relevance[1][3]. Key points: - RPL23AP91 is a non-coding pseudogene and does not represent a receptor, enzyme, or other target class relevant for drug discovery or therapy[3]. - No data supports its use in biomarkers, drug interactions, or safety profiles. - Any link between ribosomal pseudogenes and disease generally concerns other pseudogene family members, not RPL23AP91[1]. If your interest is in a therapeutic "target," this entry should be recorded as non-target and potentially excluded from further target-based analyses.

Other names

RPL23A pseudogene 91RPL23AP91